Volume 47, Issue 2, Pages (February 2005)

Slides:



Advertisements
Similar presentations
The future perspectives in transrectal prostate ultrasound guided biopsy Sung Il Hwang, Hak Jong Lee Prostate International Volume 2, Issue 4, Pages
Advertisements

Volume 369, Issue 9580, Pages (June 2007)
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 49, Issue 2, Pages (February 2006)
Reversible, Non-Barrier Male Contraception: Status and Prospects
Female Urinary Incontinence in the West of Turkey: Prevalence, Risk Factors and Impact on Quality of Life  Izzet Kocak, Pinar Okyay, Mehmet Dundar, Haluk.
Volume 70, Issue 1, Pages (July 2016)
Testosterone Therapy in Men With Prostate Cancer
Volume 49, Issue 2, Pages (February 2006)
Volume 49, Issue 2, Pages (February 2006)
Validity and Reliability of a Questionnaire for Evaluating Nocturia, Nocturnal Enuresis and Sleep-Interruptions in an Elderly Population  M.H. Bing, L.A.
Volume 51, Issue 4, Pages (April 2007)
Volume 53, Issue 5, Pages (May 2008)
Metastatic Spermatocytic Seminoma – An Extremely Rare Disease
Let the Games Begin (with EAU Approval)
Prostate Cancer Epidemic in Sight?
Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer  Olav Erich Yri, Trine Bjoro, Sophie D.
John P. Mulhall, Francesco Montorsi  European Urology 
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
The Long-Term Outcome of Medical Therapy for BPH
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH)  Raymond C. Rosen, Francois Giuliano, Culley.
Volume 54, Issue 4, Pages (October 2008)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 48, Issue 6, Pages (December 2005)
Prostate Cancer Detection: A View of the Future
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 68, Issue 1, Pages (July 2015)
Volume 64, Issue 4, Pages (October 2013)
Volume 70, Issue 1, Pages (July 2016)
Volume 47, Issue 5, Pages (May 2005)
Prostate Cancer Epidemic in Sight?
Volume 48, Issue 4, Pages (October 2005)
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 70, Issue 6, Pages (December 2016)
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Treatment of Bacterial Urinary Tract Infections: Presence and Future
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Paolo Puppo, Carlo Introini, Paolo Calvi, Angelo Naselli 
Metastatic Spermatocytic Seminoma – An Extremely Rare Disease
Volume 47, Issue 1, Pages (January 2005)
The Economic Costs of Overactive Bladder in Germany
Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl  European Urology 
Volume 50, Issue 5, Pages (November 2006)
Volume 46, Issue 5, Pages (November 2004)
Adult Stem Cell Therapy of Female Stress Urinary Incontinence
Volume 369, Issue 9580, Pages (June 2007)
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Volume 52, Issue 6, Pages (December 2007)
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
Testicular Cancer Variations in Time and Space in Europe
Volume 26, Issue 2, Pages (February 2018)
European Urology is “Your” Journal
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer  P. Mongiat-Artus, P. Teillac 
Volume 52, Issue 4, Pages (October 2007)
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) 
Volume 53, Issue 2, Pages (February 2008)
Bertrand Tombal, Richard Berges
Joaquim Bellmunt  European Urology Supplements 
Integrating Patient Risk Profiles in the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) in Clinical Practice 
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Impact of antibiotic restrictions: the patient's perspective
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 47, Issue 2, Pages 243-249 (February 2005) Effects of Local Estrogen Therapy on Recurrent Urinary Tract Infections in Young Females under Oral Contraceptives  Germar-M. Pinggera, Gudrun Feuchtner, Ferdinand Frauscher, Peter Rehder, Hannes Strasser, Georg Bartsch, Ralf Herwig  European Urology  Volume 47, Issue 2, Pages 243-249 (February 2005) DOI: 10.1016/j.eururo.2004.09.008 Copyright © 2004 Elsevier B.V. Terms and Conditions

Fig. 1 Recurrence rate of infections after one year of observation in patients with RUTI after E3 therapy. European Urology 2005 47, 243-249DOI: (10.1016/j.eururo.2004.09.008) Copyright © 2004 Elsevier B.V. Terms and Conditions

Fig. 2 Power Doppler ultrasound image and RI measurement before E3 therapy. European Urology 2005 47, 243-249DOI: (10.1016/j.eururo.2004.09.008) Copyright © 2004 Elsevier B.V. Terms and Conditions

Fig. 3 Power Doppler ultrasound image and RI measurement after E3 therapy. European Urology 2005 47, 243-249DOI: (10.1016/j.eururo.2004.09.008) Copyright © 2004 Elsevier B.V. Terms and Conditions

Fig. 4 Type of contraception used one year after E3 therapy for RUTI. European Urology 2005 47, 243-249DOI: (10.1016/j.eururo.2004.09.008) Copyright © 2004 Elsevier B.V. Terms and Conditions